Advances in MRI research on the brain structure and function in chronic obstructive pulmonary disease

LI Kun; LI Ning; YANG Jianya; ZHANG Jingyi; ZHANG Xu; LI Suyun

doi:10.12122/j.issn.1674-4500.2024.03.18

Volume 47 Issue 3

Mar. 2024

Turn off MathJax

Article Contents

Article Navigation > Journal of Molecular Imaging > 2024 > 47(3): 331-335

LI Kun, LI Ning, YANG Jianya, ZHANG Jingyi, ZHANG Xu, LI Suyun. Advances in MRI research on the brain structure and function in chronic obstructive pulmonary disease[J]. Journal of Molecular Imaging, 2024, 47(3): 331-335. doi: 10.12122/j.issn.1674-4500.2024.03.18

Citation:

LI Kun, LI Ning, YANG Jianya, ZHANG Jingyi, ZHANG Xu, LI Suyun. Advances in MRI research on the brain structure and function in chronic obstructive pulmonary disease[J]. Journal of Molecular Imaging, 2024, 47(3): 331-335. doi: 10.12122/j.issn.1674-4500.2024.03.18

Citation:

PDF( 1072 KB)

Advances in MRI research on the brain structure and function in chronic obstructive pulmonary disease

doi: 10.12122/j.issn.1674-4500.2024.03.18

LI Kun^1
,,
LI Ning²,
YANG Jianya²,
ZHANG Jingyi¹,
ZHANG Xu¹,
LI Suyun^{2
,
,}

1.
Henan University of Chinese Medicine, Zhengzhou 450046, China
2.
The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou 450000, China

Funds: Supported by National Natural Science Foundation of China(82074413)

Received Date: 2023-11-02
Available Online: 2024-04-17
Publish Date: 2024-03-20

Abstract

Abstract

Chronic obstructive pulmonary disease can not only involve the lungs but also cause systemic adverse reactions, and extrapulmonary effects can aggravate its severity, in which brain damage is gradually gaining attention from researchers. In recent years, neurological imaging technology has made great progress, especially based on voxel morphometry, diffusion tensor imaging, magnetic resonance spectroscopy and functional magnetic resonance imaging, which can not only non-invasively observe and detect the morphology and structure of the body, but also provide microcosmic information such as functional metabolism. This article reviews the characteristics, possible mechanism and research status of brain structural and functional changes in patients with chronic obstructive pulmonary disease from the perspective of MRI multi-parameter imaging, with a view to the more extensive and mature application of MRI in the field of neuroscience and the study of central nervous system diseases. Thus, it provides a new method and important information for further study and study of the pathophysiological mechanism of chronic obstructive pulmonary disease, clinical diagnosis and treatment and prognosis of the disease.
- chronic obstructive pulmonary disease,
- magnetic resonance imaging technology,
- brain damage,
- brain structure and function,
- research progress

FullText(HTML)

References(51)

References

[1]	Agustí A, Celli BR, Criner GJ, et al. Global initiative for chronic obstructive lung disease 2023 report: gold executive summary[J]. Respirology, 2023, 28(4): 316-38.
[2]	Wang C, Xu JY, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health[CPH]study): a national cross-sectional study[J]. Lancet, 2018, 391(10131): 1706-17.
[3]	Halpin DMG. Systemic effects of chronic obstructive pulmonary disease[J]. Expert Rev Respir Med, 2007, 1(1): 75-84. doi: 10.1586/17476348.1.1.75
[4]	Agusti À, Soriano JB. COPD as a systemic disease[J]. COPD J Chronic Obstr Pulm Dis, 2008, 5(2): 133-8. doi: 10.1080/15412550801941349
[5]	Kim V, Crapo J, Zhao HQ, et al. Comparison between an alternative and the classic definition of chronic bronchitis in COPDGene[J]. Ann Am Thorac Soc, 2015, 12(3): 332-9. doi: 10.1513/AnnalsATS.201411-518OC
[6]	Goldstein PC. Drawing impairment predicts mortality in severe COPD: a naive approach to COPD mortality prediction[J]. Chest, 2007, 132(4): 1411-2.
[7]	丁元庆. 慢性脑损伤病因病机解析[J]. 山东中医杂志, 2017, 36(9): 731-3. https://www.cnki.com.cn/Article/CJFDTOTAL-SDZY201709001.htm
[8]	Dodd JW, Getov SV, Jones PW. Cognitive function in COPD[J]. Eur Respir J, 2010, 35(4): 913-22. doi: 10.1183/09031936.00125109
[9]	Grant I, Heaton RK, McSweeny AJ, et al. Neuropsychologic findings in hypoxemic chronic obstructive pulmonary disease[J]. Arch Intern Med, 1982, 142(8): 1470-6. doi: 10.1001/archinte.1982.00340210062015
[10]	Dodd JW, Charlton RA, van den Broek MD, et al. Cognitive dysfunction in patients hospitalized with acute exacerbation of COPD[J]. Chest, 2013, 144(1): 119-27. doi: 10.1378/chest.12-2099
[11]	Antonelli-Incalzi R, Corsonello A, Pedone C, et al. Drawing impairment predicts mortality in severe COPD[J]. Chest, 2006, 130(6): 1687-94. doi: 10.1378/chest.130.6.1687
[12]	Zarowitz BJ, O'Shea T. Chronic obstructive pulmonary disease: prevalence, characteristics, and pharmacologic treatment in nursing home residents with cognitive impairment[J]. J Manag Care Pharm, 2012, 18(8): 598-606.
[13]	Antonelli-Incalzi R, Corsonello A, Trojano L, et al. Correlation between cognitive impairment and dependence in hypoxemic COPD[J]. J Clin Exp Neuropsychol, 2008, 30(2): 141-50. doi: 10.1080/13803390701287390
[14]	Wang CR, Ding YH, Shen BX, et al. Altered gray matter volume in stable chronic obstructive pulmonary disease with subclinical cognitive impairment: an exploratory study[J]. Neurotox Res, 2017, 31(4): 453-63. doi: 10.1007/s12640-016-9690-9
[15]	Zhang H, Wang X, Lin J, et al. Reduced regional gray matter volume in patients with chronic obstructive pulmonary disease: a voxel-based morphometry study[J]. AJNR Am J Neuroradiol, 2013, 34(2): 334-9. doi: 10.3174/ajnr.A3235
[16]	Kirkil G, Tug T, Ozel E, et al. The evaluation of cognitive functions with P300 test for chronic obstructive pulmonary disease patients in attack and stable period[J]. Clin Neurol Neurosurg, 2007, 109(7): 553-60. doi: 10.1016/j.clineuro.2007.03.013
[17]	Antonelli Incalzi R, Marra C, Giordano A, et al. Cognitive impairment in chronic obstructive pulmonary disease[J]. J Neurol, 2003, 250(3): 325-32. doi: 10.1007/s00415-003-1005-4
[18]	Daulatzai MA. Death by a thousand cuts in Alzheimer's disease: hypoxia: the prodrome[J]. Neurotox Res, 2013, 24(2): 216-43. doi: 10.1007/s12640-013-9379-2
[19]	Peña F, Ramirez JM. Hypoxia-induced changes in neuronal network properties[J]. Mol Neurobiol, 2005, 32(3): 251-83. doi: 10.1385/MN:32:3:251
[20]	Teppema LJ, Dahan A. The ventilatory response to hypoxia in mammals: mechanisms, measurement, and analysis[J]. Physiol Rev, 2010, 90(2): 675-754. doi: 10.1152/physrev.00012.2009
[21]	Siraj RA. Comorbid cognitive impairment in chronic obstructive pulmonary disease (COPD): current understanding, risk factors, implications for clinical practice, and suggested interventions[J]. Medicina, 2023, 59(4): 732. doi: 10.3390/medicina59040732
[22]	Lehmenkühler A, Bingmann D, Speckmann EJ. Neuronal and glial responses to hypoxia and hypercapnia[J]. Biomed Biochim Acta, 1989, 48(2/3): S155-60.
[23]	Marshall O, Uh J, Lurie D, et al. The influence of mild carbon dioxide on brain functional homotopy using resting-state fMRI[J]. Hum Brain Mapp, 2015, 36(10): 3912-21. doi: 10.1002/hbm.22886
[24]	Grant I, Prigatano GP, Heaton RK, et al. Progressive neuropsychologic impairment and hypoxemia. Relationship in chronic obstructive pulmonary disease[J]. Arch Gen Psychiatry, 1987, 44(11): 999-1006. doi: 10.1001/archpsyc.1987.01800230079013
[25]	戈艳蕾, 刘聪辉, 崔紫阳, 等. 慢性阻塞性肺疾病合并阻塞性睡眠呼吸暂停综合征患者血清Caspase-3和Caspase-9水平与认知功能障碍的相关性研究[J]. 中国现代医学杂志, 2016, 26(11): 77-80. doi: 10.3969/j.issn.1005-8982.2016.11.016
[26]	Duong T, Acton PJ, Johnson RA. The in vitro neuronal toxicity of pentraxins associated with Alzheimer's disease brain lesions[J]. Brain Res, 1998, 813(2): 303-12. doi: 10.1016/S0006-8993(98)00966-4
[27]	Campos MW, Serebrisky D, Castaldelli-Maia JM. Smoking and cognition[J]. Curr Drug Abuse Rev, 2016, 9(2): 76-9.
[28]	Hanlon CA, Owens MM, Joseph JE, et al. Lower subcortical gray matter volume in both younger smokers and established smokers relative to non-smokers[J]. Addict Biol, 2016, 21(1): 185-95. doi: 10.1111/adb.12171
[29]	Aras YG, Tunç A, Güngen BD, et al. The effects of depression, anxiety and sleep disturbances on cognitive impairment in patients with chronic obstructive pulmonary disease[J]. Cogn Neurodyn, 2017, 11(6): 565-71. doi: 10.1007/s11571-017-9449-x
[30]	陈秋艳, 蒋育悦, 胡如海, 等. 慢性阻塞性肺疾病患者认知功能障碍的研究进展[J]. 实用临床医药杂志, 2021, 25(1): 117-20. https://www.cnki.com.cn/Article/CJFDTOTAL-XYZL202101030.htm
[31]	Guarnieri B, Sorbi S. Sleep and cognitive decline: a strong bidirectional relationship. it is time for specific recommendations on routine assessment and the management of sleep disorders in patients with mild cognitive impairment and dementia[J]. Eur Neurol, 2015, 74(1/2): 43-8.
[32]	Whitwell JL. Voxel-based morphometry: an automated technique for assessing structural changes in the brain[J]. J Neurosci, 2009, 29(31): 9661-4. doi: 10.1523/JNEUROSCI.2160-09.2009
[33]	Ridgway GR, Henley SM, Rohrer JD, et al. Ten simple rules for reporting voxel-based morphometry studies[J]. Neuroimage, 2008, 40(4): 1429-35. doi: 10.1016/j.neuroimage.2008.01.003
[34]	Yin MM, Wang HB, Hu XW, et al. Patterns of brain structural alteration in COPD with different levels of pulmonary function impairment and its association with cognitive deficits[J]. BMC Pulm Med, 2019, 19(1): 203. doi: 10.1186/s12890-019-0955-y
[35]	Wang W, Wang P, Li QC, et al. Alterations of grey matter volumes and network-level functions in patients with stable chronic obstructive pulmonary disease[J]. Neurosci Lett, 2020, 720: 134748. doi: 10.1016/j.neulet.2020.134748
[36]	Zhang HY, Wang XC, Lin JZ, et al. Grey and white matter abnormalities in chronic obstructive pulmonary disease: a case-control study[J]. BMJ Open, 2012, 2(2): e000844. doi: 10.1136/bmjopen-2012-000844
[37]	Chen J, Lin IT, Zhang HY, et al. Reduced cortical thickness, surface area in patients with chronic obstructive pulmonary disease: a surface-based morphometry and neuropsychological study[J]. Brain Imaging Behav, 2016, 10(2): 464-76. doi: 10.1007/s11682-015-9403-7
[38]	Lee S, Pyun SB, Tae WS. Reduced axial diffusivity and increased mode and T2 signals in cerebral white matter of chronic obstructive pulmonary disease using tract-based spatial statistics[J]. Neuroradiology, 2019, 61(7): 795-801. doi: 10.1007/s00234-019-02178-0
[39]	Charlton RA, Schiavone F, Barrick TR, et al. Diffusion tensor imaging detects age related white matter change over a 2 year follow-up which is associated with working memory decline[J]. J Neurol Neurosurg Psychiatry, 2010, 81(1): 13-9. doi: 10.1136/jnnp.2008.167288
[40]	Dodd JW, Chung AW, van den Broek MD, et al. Brain structure and function in chronic obstructive pulmonary disease: a multimodal cranial magnetic resonance imaging study[J]. Am J Respir Crit Care Med, 2012, 186(3): 240-5. doi: 10.1164/rccm.201202-0355OC
[41]	Han XM, Tian HJ, Han Z, et al. Correlation between white matter damage and gray matter lesions in multiple sclerosis patients[J]. Neural Regen Res, 2017, 12(5): 787-94. doi: 10.4103/1673-5374.206650
[42]	Spilling CA, Bajaj MP K, Burrage DR, et al. Contributions of cardiovascular risk and smoking to chronic obstructive pulmonary disease (COPD)-related changes in brain structure and function[J]. Int J Chron Obstruct Pulmon Dis, 2019, 14: 1855-66. doi: 10.2147/COPD.S213607
[43]	Zang YF, Jiang TZ, Lu YL, et al. Regional homogeneity approach to fMRI data analysis[J]. NeuroImage, 2004, 22(1): 394-400. doi: 10.1016/j.neuroimage.2003.12.030
[44]	Zhang JX, Chen J, Yu Q, et al. Alteration of spontaneous brain activity in COPD patients[J]. Int J Chron Obstruct Pulmon Dis, 2016, 11: 1713-9. doi: 10.2147/COPD.S110089
[45]	Wang WJ, Li HJ, Peng DC, et al. Abnormal intrinsic brain activities in stable patients with COPD: a resting-state functional MRI study[J]. Neuropsychiatr Dis Treat, 2018, 14: 2763-72. doi: 10.2147/NDT.S180325
[46]	Watanabe T, Frahm J, Michaelis T. Amide proton signals as pH indicator for in vivo MRS and MRI of the brain-Responses to hypercapnia and hypothermia[J]. NeuroImage, 2016, 133: 390-8. doi: 10.1016/j.neuroimage.2016.03.013
[47]	Martin AR, Aleksanderek I, Cohen-Adad J, et al. Translating state-of-the-art spinal cord MRI techniques to clinical use: a systematic review of clinical studies utilizing DTI, MT, MWF, MRS, and fMRI[J]. Neuroimage Clin, 2016, 10: 192-238. doi: 10.1016/j.nicl.2015.11.019
[48]	Murphy PS, Rowland IJ, Viviers L, et al. Could assessment of glioma methylene lipid resonance by in vivo (1)H-MRS be of clinical value?[J]. Br J Radiol, 2003, 76(907): 459-63. doi: 10.1259/bjr/16316438
[49]	Basilakos A, Stark BC, Johnson L, et al. Leukoaraiosis is associated with a decline in language abilities in chronic aphasia[J]. Neurorehabil Neural Repair, 2019, 33(9): 718-29. doi: 10.1177/1545968319862561
[50]	Barreto PR, Diniz DLO, Lopes JP, et al. Obstructive sleep apnea and wake-up stroke - A 12 months prospective longitudinal study[J]. J Stroke Cerebrovasc Dis, 2020, 29(5): 104564. doi: 10.1016/j.jstrokecerebrovasdis.2019.104564
[51]	Fragoso CAV, Gill TM, Leo-Summers LS, et al. Spirometric criteria for chronic obstructive pulmonary disease in clinical trials of pharmacotherapy[J]. COPD, 2018, 15(1): 17-20. doi: 10.1080/15412555.2018.1424815

Relative Articles

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (27) PDF downloads(7)

Advances in MRI research on the brain structure and function in chronic obstructive pulmonary disease

doi: 10.12122/j.issn.1674-4500.2024.03.18

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Advances in MRI research on the brain structure and function in chronic obstructive pulmonary disease

doi: 10.12122/j.issn.1674-4500.2024.03.18

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Export File

Citation

Format

Content